Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease

Journal of the American Society of Nephrology

Volumn 22, Issue 10, 2011, Pages 1946-1952

  Olson, Stephen W ^a   Arbogast, Charles B ^b   Baker, Thomas P ^a   Owshalimpur, David ^c   Oliver, David K ^a   Abbott, Kevin C ^a   Yuan, Christina M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 80053466078     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010090928     Document Type: Article

References (35)

1. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome: Goodpasture's syndrome, and type IV collagen. N Engl J Med 348: 2543-2556, 2003 (Pubitemid 36706542)
2. Kluth DC, Rees AJ: Anti-glomerular basement membrane disease. J Am Soc Nephrol 10: 2446-2453, 1999 (Pubitemid 29501480)
3. Kalluri R: Goodpasture syndrome. Kidney Int 55: 1120-1122, 1999
4. Rosenblum ND, Colvin RB: Case 16-1993: A 13-year-old girl with gross hematuria four years after a diagnosis of idiopathic pulmonary hemosiderosis. N Engl J Med 328: 1183-1190, 1993
5. Lionaki S, Jennette JC, Falk RJ: Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol 29: 459-474, 2007 (Pubitemid 350077264)
6. Cui Z, Wang H, Zhao M: Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 69: 894-899, 2006
7. Yang R, Cui Z, Hellmark T, Segelmark M, Zhao M, Wang H: Natural anti-GBM antibodies from normal sera recognize α(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 124: 207-212, 2007 (Pubitemid 47064520)
8. Salama AD, Chaudhry AN, Ryan J, Eren E, Levy JB, Pusey CD, Lightstone L, Lechler RI: Goodpasture's disease: CD4+ T-cells escape thymic deletion and are reactive with the autoantigen α3(IV)NC1. J Am Soc Nephrol 12: 1908-1915, 2001 (Pubitemid 32801366)
9. Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching R, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG: Molecular architecture of the goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363: 343-354, 2010
10. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GL, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533, 2003 (Pubitemid 37255038)
11. Serratrice J, Chiche L, Dussol B, Granel B, Daniel L, Jego-Desplat S, Disdier P, Swiader L, Berland Y, Weiller PJ: Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 43: 26-30, 2004
12. Verburgh CA, Brujin JA, Daha MR, Es LAV: Sequential development of anti-GBM nephritis and ANCA-associated pauci-immune glomerulonephritis. Am J Kidney Dis 34: 344-348, 1999 (Pubitemid 29362103)
13. Wahls TL, Bonsib SM, Schuster VL: Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease. Hum Pathol 18: 202-205, 1987 (Pubitemid 17024352)
14. Gallagher JL, Sinha S, Reeve R, Kalra P: Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis. Postgrad Med J 84: 220-222, 2008 (Pubitemid 351600794)
15. Fanburg BL, Niles JL, Mark EJ: Case 52-1993: A 17-year-old girl with massive hemoptysis and acute oliguric renal failure. N Engl J Med 329: 2019-2026, 1993 (Pubitemid 24015047)
16. Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao M, Wang H: Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with Goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 18: 1338-1343, 2007 (Pubitemid 46536921)
17. Rutgers A, Slot M, Paassen PV, Vriesman PVB, Heeringa P, Tervaert JWC: Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 46: 253-262, 2005 (Pubitemid 41040353)
18. Clyne S, Frederick C, Arndt F, Lewis J, Fogo AB: Concurrent and discrete clinicopathological presentations of Wegener granulomatosis and anti-glomerular basement membrane disease. Am J Kidney Dis 54: 1116-1120, 2009
19. Zou J, Hannier S, Cairns LS, Barker RN, Rees AJ, Turner AN, Phelps RG: Healthy individuals have Goodpasture autoantigen reactive T cells. J Am Soc Nephrol 19: 396-404, 2008 (Pubitemid 351240661)
20. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 181: 1957-1963, 1995
21. Zou J, Henderson L, Thomas V, Swan P, Turner AN, Phelps RG: Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes. J Am Soc Nephrol 18: 771-779, 2007 (Pubitemid 46434494)
22. Wallin EF, Jayne DR: Anti-glomerular basement membrane disease after alemtuzumab. N Engl J Med 359: 768-769, 2008
23. Klassen J, Elwood C, Grossberg AL, Milgrom F, Montes M, Sepulveda M, Andres GA: Evolution of membranous nephropathy into anti-glomerular-basement- membrane glomerulonephritis. N Engl J Med 290: 1340-1344, 1974
24. Moorthy AV, Zimmermann SW: Burkholder PM, Harrington AR: Association of crescentic glomerulonephritis with membranous glomerulopathy: A report of three cases. Clin Nephrol 6: 319-325, 1976
25. Xenocostas A, Jothy S, Collins B, Loertscher R, Levy M: Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis 33: 128-132, 1999 (Pubitemid 29031219)
26. Yaqoob M, Pai P, Bell GM: Biochemical markers of basement membrane disturbances and occupational exposure to hydrocarbons and mixed solvents. QJM 88: 23-28, 1995
27. Arends J, Wu J, Borillo J, Troung L, Zhou C, Vigneswaran N, Lou Y: T-cell epitope mimicry in antiglomerular basement membrane disease. J Immunol 176: 1252-1258, 2006 (Pubitemid 43099730)
28. Mesnard L, Keller ADC, Michel ML, Vandermeersch S, Rafat C, Letavernier E, Tellet Y, Rondeau E, Leite-de-Moraes MC: Invariant natural killer T cells and TGF-β attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol 20: 1282-1292, 2009
29. Ooi JD, Phoon RKS, Holdsworth SR, Kitching R: IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol 20: 980-989, 2009
30. Borza DB: Autoepitopes and alloepitopes of type IV collagen: Role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis. Nephron Exp Nephrol 106: e37-e43, 2007
31. Sinico RA, Radice A, Corace C, Sabadini E, Bollini B: Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: A comparison of different assays. Nephrol Dial Transplant 21: 397-401, 2006 (Pubitemid 43159994)
32. Jaskowski TD, Martins TB, Litwin CM, Hill HR: Comparison of four enzyme immunoassays for the detection of immunoglobulin G antibody against glomerular basement membrane. J Clin Lab Anal 16: 143-145, 2002 (Pubitemid 34492366)
33. Litwin GM, Mouritsen CL, Wilfahrt PA, Schroder MC, Hill HR: Antiglomerular basement membrane disease: Role of enzyme-linked immunosorbent assays in diagnosis. Biochem Mol Med 59: 52-56, 1996 (Pubitemid 26346758)
34. Lifton RP: Individual genomes on the horizon. N Engl J Med 362: 1235-1236, 2010
35. Abbott KC, Bohen EM, Yuan CM, Yeo FE, Sawyers ES, Perkins RM, Lentine KL, Oliver DK, Galey J, Sebastianelli ME, Scally JP, Taylor AJ, Boal TR: Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system. Am J Kidney Dis 47: 593-603, 2006